CHALFONT, PA--(Marketwired - September 23, 2013) - Genomind, a personalized medicine company in neuropsychiatry, is excited to announce the launch of their new clinician portal. The new Genomind ...

Genomind, a King of Prussia-based mental health company, and NeuroFlow, a Philadelphia-based health care analytics and technology company, recently announced an agreement to partner their proprietary ...

“NextUp” is a weekly NextHealth PHL feature that highlights the local leaders, organizations and research shaping the Greater Philadelphia region’s life sciences ecosystem. Email [email protected] ...

Genomind’s new CORE Anxiety and Depression Report is the most advanced and comprehensive depression and anxiety-focused service available in the mental health PGx market. It analyzes 15 genes that ...

A King of Prussia, Pa., personalized medicine company that has developed a genetic test to help clinicians make more informed treatment decisions for patients with depression has raised another $3.5 ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now available to ...

PHILADELPHIA--(BUSINESS WIRE)-- Audacy announced a multiplatform partnership with mental health innovator Genomind. This breakthrough partnership taps into Audacy’s influencers and Genomind’s ...

KING OF PRUSSIA, PA--(Marketwired - January 09, 2017) - In 2016, more Americans underwent genetic testing performed by Genomind (www.genomind.com) to help guide treatment of mental illness than in any ...

The company is seeking to raise additional funding. Genomind, area Acme parent partner to up awareness of genetic tes Montco firm introduces its latest genetic mental health tool Montco firm ...

KING OF PRUSSIA, PA--(Marketwired - February 08, 2017) - Genomind, a personalized medicine company advancing mental healthcare through genetic testing, has completed an $11 million financing with its ...